Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

MoliChem Medicines reports successful result of phase I trial evaluating potential CF treatment

May 23, 2000

Benzazine derivatives as selective PDE4 inhibitors

May 22, 2000

Zambon and Sheffield file for MSI-Albuterol approval via European centralized procedure

May 19, 2000

New tryptase inhibitors from Bayer useful for allergic disorders

May 18, 2000

Schering-Plough presents new humanized anti-IL-5 MAbs for asthma

May 18, 2000

Bronchodilating PDE4 inhibitors synthesized and tested by Dainippon

May 17, 2000

Orphan drug status granted for Merrem I.V. as cystic fibrosis treatment

May 17, 2000

Tiotropium bromide produces long-lasting bronchodilatation in patients with COPD

May 16, 2000

Naphthalenecarboxamide-based tachykinin antagonists in development by AstraZeneca

May 15, 2000

Bayer presents new PDE inhibitor in development for COPD and asthma

May 12, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Antares Therapeutics divulges new CDK2/cyclin E1 inhibitors
BioWorld Science
Antares Therapeutics Inc. has reported new CDK2/cyclin E1 inhibitors potentially useful for the treatment of cancer.
Empire Discovery Institute, Univ. of Rochester identify IRAK inhibitors
BioWorld Science
Empire Discovery Institute and the University of Rochester have discovered new interleukin-1 receptor-associated kinase 1 (IRAK-1) and/or IRAK-4 inhibitors...